Replies to post #177911 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I must say I doubt that because there is nothing particular about the protocol or endpoints for the trials that we at last have witnessed, which required new FDA guidance or rules.

[mapman1010]

Yep, exactly what I was thinking.

More evidence that the 2017 trial delay was due to FDA structural issues, not alleged milestone misses on Missling's part.